Inserts Containing Combination Therapy May Protect Women Against HIV – APhA submits compounding comments to FDA.

7Alabama Defense Lawyer, Board of Pharmacy, Pharmacy Defense Attorney, KLF

Inserts Containing Combination Therapy May Protect Women Against HIV – APhA submits compounding comments to FDA. – (866) 348-2889.

Vaginal inserts containing tenofovir alafenamide fumarate (TAF) in combination with elvitegravir (EVG) may help protect women against HIV infection.

Data compiled from a recent study showed that this therapy was highly effective in preventing simian/HIV (SHIV) infection in a macaque model mimicking vaginal transmission of HIV. 1

Results of the study were presented last week at the Conference on Retroviruses and Opportunistic Infections in Seattle, Washington. 

CLICK HERE FOR CONTINUE READING

This entry was posted in Pharmacist and tagged , , , . Bookmark the permalink.

Comments are closed.